Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 Dec;86(4):869–875. doi: 10.1111/j.1476-5381.1985.tb11109.x

Effect of some monoamine oxidase inhibitors on the thiamin status of rabbits.

B H Ali
PMCID: PMC1916620  PMID: 4075020

Abstract

The monamine oxidase (MAO) inhibitors harmaline, tranylcypromine, deprenyl, clorgyline and iproniazid were injected intraperitoneally for five days to rabbits at doses that produced significant MAO inhibition. The first three inhibitors raised the concentrations of pyruvate and lactate in blood, decreased the activity of erythrocyte transketolase (TK) and increased the thiamin pyrophosphate (TPP) effect. The drugs also produced anorexia and loss of body weight. The changes were suggestive of an adverse effect on the thiamin status. Clorgyline and iproniazid, however, raised the blood concentrations of pyruvate and lactate but did not affect significantly erythrocyte TK activity or TPP effect. Treatment of rabbits for 14 days with the thiamin antagonists pyrithiamine (20 micrograms kg-1) or oxythiamine (0.8 mg kg-1) produced a significant drop in TK activity and increase in the lactate and pyruvate concentrations as well as an increase in TPP effect. Pyrithiamine (5, 10 or 20 micrograms kg-1, 14 days) lowered significantly the activity of MAO in the liver and brain of rabbits. Treatment with the other antagonist, oxythiamine, at doses of 0.2 or 0.4 mg kg-1 for 14 days had no significant effect on MAO activity. At a dose of 0.8 mg kg-1 a significant drop in MAO activity occurred. A pair-feeding trial indicated that the biochemical changes produced in animals treated with MAO inhibitors were attributable to the drugs per se, and not to the ensuing anorexia. Thiamin (100 micrograms kg-1, subcutaneously) when given concomitantly with pyrithiamine, oxythiamine, harmaline, deprenyl and tranylcypromine was effective in preventing the development of thiamin deficiency.

Full text

PDF
869

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali B. H., Bartlet A. L. Anorexia and antagonism of thiamin utilization in poultry treated with furazolidone. Q J Exp Physiol. 1982 Jul;67(3):437–448. doi: 10.1113/expphysiol.1982.sp002659. [DOI] [PubMed] [Google Scholar]
  2. BRIN M., SHOHET S. S., DAVIDSON C. S. The effect of thiamine deficiency on the glucose oxidative pathway of rat erythrocytes. J Biol Chem. 1958 Jan;230(1):319–326. [PubMed] [Google Scholar]
  3. Bai P., Bennion M., Gubler C. J. Biochemical factors involved in the anorexia of thiamin deficiency in rats. J Nutr. 1971 Jun;101(6):731–737. doi: 10.1093/jn/101.6.731. [DOI] [PubMed] [Google Scholar]
  4. Boni L., Kieckens L., Hendrikx A. An evaluation of a modified erythrocyte transketolase assay for assessing thiamine nutritional adequacy. J Nutr Sci Vitaminol (Tokyo) 1980;26(5):507–514. doi: 10.3177/jnsv.26.507. [DOI] [PubMed] [Google Scholar]
  5. Connor D. J. Thiamine intake and monoamine oxidase activity. Biol Psychiatry. 1981 Sep;16(9):869–872. [PubMed] [Google Scholar]
  6. GAL E. M., DREWES P. A. Studies on the metabolism of 5-hydroxytryptamine (serotonin). I. Effect of starvation and thiamine deficiency. Proc Soc Exp Biol Med. 1961 Feb;106:295–297. doi: 10.3181/00379727-106-26314. [DOI] [PubMed] [Google Scholar]
  7. GEY K. F., PLETSCHER A. Increase of pyruvic and lactic acid in rat blood by inhibitors of monoamine oxidase. Experientia. 1961 Jan 15;17:25–27. doi: 10.1007/BF02157932. [DOI] [PubMed] [Google Scholar]
  8. Iwata H. Catecholamine metabolism in thiamine-deficient rats. J Nutr Sci Vitaminol (Tokyo) 1976 Aug;22(Suppl):25–27. doi: 10.3177/jnsv.22.supplement_25. [DOI] [PubMed] [Google Scholar]
  9. Iwata H., Nishikawa T., Fujimoto S. Monoamine oxidase activities in tissues of thiamine-deficient rats. J Pharm Pharmacol. 1969 Apr;21(4):237–240. doi: 10.1111/j.2042-7158.1969.tb08238.x. [DOI] [PubMed] [Google Scholar]
  10. Lonsdale D., Shamberger R. J. Red cell transketolase as an indicator of nutritional deficiency. Am J Clin Nutr. 1980 Feb;33(2):205–211. doi: 10.1093/ajcn/33.2.205. [DOI] [PubMed] [Google Scholar]
  11. MELTZER H. Y. The effect of thiamine on monoamine oxidase. Biochem Pharmacol. 1961 Aug;7:277–278. doi: 10.1016/0006-2952(61)90095-8. [DOI] [PubMed] [Google Scholar]
  12. Marbach E. P., Weil M. H. Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant. Clin Chem. 1967 Apr;13(4):314–325. [PubMed] [Google Scholar]
  13. Pare C. M. Monoamine oxidase inhibitors in resistant depression. Int Pharmacopsychiatry. 1979;14(2):101–109. doi: 10.1159/000468364. [DOI] [PubMed] [Google Scholar]
  14. Saner A., Weiser H., Hornig D., Da Prada M., Pletscher A. Cerebral monoamine metabolism in guinea-pigs with ascorbic acid deficiency. J Pharm Pharmacol. 1975 Dec;27(12):896–902. doi: 10.1111/j.2042-7158.1975.tb10244.x. [DOI] [PubMed] [Google Scholar]
  15. WEISSBACH H., SMITH T. E., DALY J. W., WITKOP B., UDENFRIEND S. A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine. J Biol Chem. 1960 Apr;235:1160–1163. [PubMed] [Google Scholar]
  16. Wood B., Breen K. J., Penington D. G. Thiamine status in alcoholism. Aust N Z J Med. 1977 Oct;7(5):475–484. doi: 10.1111/j.1445-5994.1977.tb03368.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES